Spiros Hiotis

Saronic Biotechnology, Inc. was founded and is led by Spiros Hiotis, M.D. Ph.D. Spiros is a board-certified surgeon scientist with a high level of specialization in the management of hepatocellular carcinoma and viral hepatitis. Spiros received his M.D. degree from the University of Maryland and his Ph.D. from the University of South Florida. Following completion of residency in general surgery at the University of South Florida, Spiros attended fellowship training in surgical oncology at The Memorial Sloan-Kettering Cancer Center. He has many years of clinical, scientific research, and academic experience, and has held faculty appointments at the NYU Langone Medical Center and The Icahn School of Medicine at Mount Sinai Medical Center.

Spiros has collaborated with large and small biopharmaceutical companies regarding hepatitis B and HCC, including Gilead, and Merck. As a surgical oncologist and research scientist, Spiros has developed a broad network of relationships with leaders at life sciences entities and academic medical centers worldwide.